Serum Institute will start phase-III trials after clearances: ICMR on COVID vaccine
Updated:5 years, 4 months ago
Updated:5 years, 4 months ago
New Delhi, Sep 15 (ANI): Director General of Indian Council of Medical Research, Balram Bhargava on September 15 informed about the COVID-19 vaccines trial stage in India. He said, Cadila and Bharat Biotech have completed phase-I trials and Serum Institute has completed phase II-B3 trials, and will start phase-III trials after clearance. He said, "3 vaccines are at clinical trial stage in India. Cadila and Bharat Biotech have completed phase-I trials. Serum Institute has completed phase II-B3 trials, and will start phase-III trial (with 1500 patients at 14 locations) after clearances."
Updated:5 years, 1 month ago
Pan-India dry run for COVID vaccine tomorrow: Harsh Vardhan
Updated:5 years, 1 month ago
PM Modi joins world leaders in condemning US Capitol siege
Updated:5 years, 1 month ago
Indo-Japan Samvad: Buddha’s message spread out from India to world, says PM Modi
Updated:5 years, 1 month ago
Centre preparing with states for past 4 months for COVID-19 vaccination: Harsh Vardhan
Updated:5 years, 1 month ago
In Jan, India may be in position to give 1st COVID vaccine shot: Harsh Vardhan
Updated:5 years, 1 month ago
Worst is over but still need to be cautious: Health Minister on COVID-19 cases in India